Oyster Point Pharma, Inc. Quarterly Cost of Revenue in USD from Q1 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Oyster Point Pharma, Inc. quarterly/annual Cost of Revenue history and growth rate from Q1 2021 to Q3 2022.
  • Oyster Point Pharma, Inc. Cost of Revenue for the quarter ending September 30, 2022 was $1.35M.
  • Oyster Point Pharma, Inc. Cost of Revenue for the twelve months ending September 30, 2022 was $4.52M.
  • Oyster Point Pharma, Inc. annual Cost of Revenue for 2021 was $1.53M.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 $4.52M $1.35M +$1.35M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $3.17M $1.31M +$1.31M Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $1.86M $336K +$336K Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $1.53M $1.53M Oct 1, 2021 Dec 31, 2021 10-K 2022-02-24
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.